Vaishali Sanchorawala, MD, Boston University School of Medicine, Boston, MA, discusses an analysis investigating the potential for long-term survival and functional cure in patients with amyloid light-chain (AL) amyloidosis. Prof. Sanchorawala highlights findings from 2,384 patients treated at the Boston University Amyloidosis Center, reporting an estimated cure fraction of 16%, with associations between functional cure, hematologic complete response, and stem cell or organ transplantation. This interview took place at the XX International Symposium on Amyloidosis (ISA 2026) in Montevideo, Uruguay.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.